-
1
Improvement of Fatigue in Patients with Ankylosing Spondylitis Receiving Tofacitinib: Analyses of a Phase 3 Randomized Controlled Trial
Published 2024-12-01Subjects: Get full text
Article -
2
-
3
Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
Published 2022-07-01Subjects: Get full text
Article -
4
Tofacitinib downregulates JAK1 and JAK3 on human intestinal monocytes and macrophages without affecting dendritic cells phenotype or function
Published 2025-06-01Subjects: “…Tofacitinib…”
Get full text
Article -
5
To study the role of tofacitinib and betamethasone pulse in the treatment of vitiligo at a tertiary care centre: an observational comparative study
Published 2024-01-01Subjects: Get full text
Article -
6
Rheumatoid arthritis associated cytokines and therapeutics modulate immune checkpoint receptor expression on T cells
Published 2025-02-01Subjects: Get full text
Article -
7
-
8
Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis
Published 2025-04-01Subjects: Get full text
Article -
9
JAK inhibitors: a new choice for diabetes mellitus?
Published 2025-01-01Subjects: Get full text
Article -
10
Regulation of fibronectin and collagens type I, III and VI by TNF-α, TGF-β, IL-13, and tofacitinib
Published 2025-01-01Subjects: Get full text
Article -
11
Role of Janus Kinase inhibitors in the management of pulmonary involvement due to Long COVID-19 disease: A case control study
Published 2023-07-01Subjects: Get full text
Article -
12